How does inflammation contribute to pulmonary hypertension?
Authors:
- 25 January 2018
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 51 (1) , 1702403
Abstract
Blocking inflammation could be a curative approach in pulmonary vascular diseaseshttp://ow.ly/dW5M30hB6ajKeywords
Funding Information
- National Heart, Lung, and Blood Institute (P01HL014985, R01HL135872, R03HL133306)
- Gilead Sciences (Research Scholars Program in Pulmonary Arterial Hy)
- American Thoracic Society / Pulmonary Hypertension Association (Research Fellowship)
This publication has 31 references indexed in Scilit:
- Inflammatory Mechanisms in HIV-Associated Pulmonary Arterial HypertensionSeminars in Respiratory and Critical Care Medicine, 2013
- Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary HypertensionScience Translational Medicine, 2013
- Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary HypertensionCirculation Research, 2011
- Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary HypertensionCirculation, 2011
- Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic SclerosisCirculation, 2009
- Interleukin-6 Overexpression Induces Pulmonary HypertensionCirculation Research, 2009
- Pulmonary arterial remodeling induced by a Th2 immune responseJournal of Experimental Medicine, 2008
- Immunopathology of schistosomiasisImmunology & Cell Biology, 2006
- Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage LineageThe American Journal of Pathology, 2006
- Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung diseaseArthritis & Rheumatism, 2005